查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1919366

觸控螢幕核酸萃取儀器市場：按技術、自動化程度、處理量、應用和最終用戶分類 - 全球預測 2026-2032

Touch Screen Nucleic Acid Extraction Instrument Market by Technology, Automation Level, Throughput, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，觸控螢幕核酸萃取設備市場規模將達到 9.2561 億美元，到 2026 年將成長至 9.6077 億美元，到 2032 年將達到 13.8947 億美元，複合年成長率為 5.97%。

關鍵市場統計數據
基準年 2025 9.2561億美元
預計年份：2026年 9.6077億美元
預測年份 2032 13.8947億美元
複合年成長率 (%) 5.97%

隆重推出觸控螢幕核酸萃取儀：人性化的實驗室平台，兼具易用性、嚴謹的分子處理能力和合規性優勢。

觸控式核酸萃取儀將直覺的人機介面與精準的分子處理結合，正在重塑實驗室工作流程。這些儀器採用電容式或電阻式觸控屏，操作簡便，同時整合了先進的樣品處理、污染控制和靈活的試劑工作流程。隨著實驗室團隊尋求提高通量、增強可重複性並減輕培訓負擔，觸控平台為從學術研究人員到臨床技術人員等不同使用者群體提供了標準化通訊協定的途徑。

技術融合、分散式檢測和整合式耗材生態系統將如何從根本上改變核酸萃取工作流程和採購決策

核酸萃取領域正經歷著一場變革性的轉變，其驅動力來自於技術的融合、不斷演變的診斷需求以及檢查室模式的改變。首先，磁珠化學、微流體技術和一次性耗材設計的進步提高了萃取的穩定性，使得平台能夠處理多種類型的檢體，並保持高純度和產量的一致性。同時，模組化軟體生態系統的普及催生了更直覺的觸控螢幕介面，從而降低了操作人員的差異性，並縮短了學習曲線。

評估關稅主導的供應鏈重組對實驗室設備來源、製造地和採購優先事項的影響（截至2025年）

美國關稅政策將持續到2025年，透過改變跨境製造、採購和最終組裝的經濟模式，對全球實驗室設備和耗材供應鏈產生了影響。這些關稅迫使製造商重新評估零件的來源地，並將關鍵子組件的生產轉移到其他地方或實現多元化，以降低關稅風險，並在終端市場保持價格競爭力。因此，採購團隊越來越關注儀器和試劑的地理來源，並力求明確供應商報價中固有的關稅風險。

基於詳細細分的洞察，可協調應用程式優先順序、最終用戶操作模式、擷取技術、自動化選項和容量需求。

深入的細分分析揭示了不同應用場景、最終用戶、技術模式、自動化程度和處理容量要求所帶來的差異化需求促進因素和產品需求。基於應用領域，最終用戶對儀器的優先排序也各不相同。傳染病檢查（分為細菌和病毒檢測）對快速出結果、污染控制和臨床檢驗試劑盒有著很高的要求。而腫瘤學和基因檢測則更注重核酸完整性以及與下游定定序和擴增的兼容性。農業/食品檢測和環境檢測則需要儀器能夠適應複雜的基質並耐受抑制劑。

區域趨勢正在影響採購和部署策略，美洲、歐洲、中東和非洲以及亞太地區在法規、製造和服務期望方面各有不同。

區域趨勢揭示了影響美洲、歐洲、中東和非洲以及亞太地區（APAC）採用模式和供應商策略的不同因素。在美洲，對臨床診斷和集中式檢查室的投資正在支援全自動、高通量平台在感染疾病監測和基因組應用領域的部署。該地區的採購流程在評估設備生態系統時，強調法規遵循、品管系統和整體擁有成本。

整合產品系列、耗材生態系統和售後服務決定了供應商的競爭力，並影響實驗室設備採購框架。

觸控式核酸萃取平台的競爭格局由硬體設計、專有耗材、軟體生態系統和服務能力等整合產品組合所構成。領先供應商日益注重整合工作流程，包括提供檢驗的儀器和試劑組合、全面的合規性文件以及可延長平台使用壽命的模組化升級方案。這提高了新參與企業的進入門檻，他們不僅需要展現技術差異化優勢，還需要證明其能夠滿足長期服務和耗材需求。

製造商和服務供應商提升觸控螢幕擷取平台互通性、供應鏈韌性和客戶接受度的實用舉措

產業領導者可以透過推行一系列切實可行、注重營運的舉措，將市場動能轉化為永續的競爭優勢。首先，投資於互通性、以使用者為中心的軟體設計，將觸控螢幕控制與雲端通訊協定管理、審核追蹤和遠端支援功能結合。這將減少部署摩擦，並提高分散式實驗室網路中儀器的運轉率。其次，優先考慮檢驗的儀器-試劑組合，並發布詳細的應用說明，以加快客戶檢驗速度，並降低臨床應用門檻。

結合關鍵相關人員訪談、輔助技術檢驗和情境分析的混合研究方法，確保了研究結果的可行性和可靠性。

本研究採用混合調查方法，結合與主要相關人員的直接溝通和系統的二手研究，以提供可靠的實踐見解。主要研究內容包括與來自學術界、臨床、合約研究、食品檢測和工業實驗室的管理人員、採購負責人、臨床主任和技術負責人進行結構化訪談和定性討論。這些對話揭示了實際工作流程中的限制、採購標準以及使用者對觸控螢幕介面和萃取化學技術的期望。

總結而言，觸控螢幕擷取平台如何整合人性化的設計、分子性能和供應鏈韌性，以滿足不斷變化的實驗室需求。

觸控式核酸萃取儀在人機互動、分子性能和操作穩定性方面發揮著至關重要的作用。從感染疾病診斷到腫瘤分析，這些平台在各種應用中都提供了一條切實可行的途徑，透過整合數位控制，實現工作流程標準化、提高可重複性並支持合規性。隨著實驗室朝向分散式檢測和高級自動化發展，觸控介面將繼續有助於減輕培訓負擔，並快速擴展分子檢測能力。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依技術分類的觸控螢幕核酸萃取儀市場

  • 陰離子交換
  • 磁珠
  • 二氧化矽膜

9. 依自動化程度分類的觸控螢幕核酸萃取儀市場

  • 全自動
  • 半自動

第10章 依處理能力分類的觸控螢幕核酸萃取儀市場

  • 高通量
  • 低吞吐量
  • 中等吞吐量

第11章 按應用分類的觸控螢幕核酸萃取儀市場

  • 農業和食品檢驗
  • 環境檢查
  • 基因檢測
  • 感染疾病
    • 細菌
    • 病毒
  • 腫瘤學

第12章 依最終用戶分類的觸控螢幕核酸萃取儀市場

  • 學術研究機構
  • 臨床診斷實驗室
  • CRO
  • 食品檢驗實驗室
  • 製藥和生物技術公司

第13章 觸控螢幕核酸萃取儀市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 觸控螢幕核酸萃取儀市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國觸控螢幕核酸萃取儀市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國觸控螢幕核酸萃取設備市場

第17章：中國觸控螢幕核酸萃取儀市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Advanced Biological Laboratories SA
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Esco Micro Pte. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Geneaid Biotech Ltd.
  • NTL Biotech
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
Product Code: MRR-F14BA1B342DF

The Touch Screen Nucleic Acid Extraction Instrument Market was valued at USD 925.61 million in 2025 and is projected to grow to USD 960.77 million in 2026, with a CAGR of 5.97%, reaching USD 1,389.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 925.61 million
Estimated Year [2026] USD 960.77 million
Forecast Year [2032] USD 1,389.47 million
CAGR (%) 5.97%

Introducing touchscreen nucleic acid extraction instruments as human-centric laboratory platforms that combine ease of use with rigorous molecular processing and compliance benefits

Touch screen nucleic acid extraction instruments are reshaping laboratory workflows by combining intuitive human-machine interfaces with precision molecular processing. These instruments integrate advanced sample handling, contamination control, and flexible reagent workflows while prioritizing ease of use through capacitive or resistive touch panels. As laboratory teams seek to accelerate throughput, improve reproducibility, and lower training burden, touch-enabled platforms provide a tangible way to standardize protocols across diverse user groups, from academic investigators to clinical technicians.

The convergence of robust extraction chemistries and simplified user interfaces has broadened adoption beyond specialized molecular labs. Consequently, instrument designers now balance sophisticated automation features with software-driven user experiences that reduce procedural variability and support traceability. This shift also enables more consistent data quality downstream, improving nucleic acid yields and integrity for applications such as infectious disease diagnostics, genetic testing, oncology profiling, and agricultural testing.

Moreover, the current regulatory and quality environment places increased emphasis on auditability, electronic records, and validated workflows. Touch screen instruments help satisfy these requirements by integrating user authentication, stepwise protocol controls, and digital output that supports accreditation processes. Therefore, organizations that invest in touch screen extraction platforms can expect not only operational efficiency gains but also stronger conformity with laboratory quality systems and regulatory expectations.

Taken together, these dynamics position touch screen nucleic acid extraction instruments as a strategic tool that aligns human factors engineering with molecular performance, enabling laboratories to scale capability while preserving analytical rigor and compliance.

How technological convergence, decentralization of testing, and integrated consumable ecosystems are fundamentally transforming nucleic acid extraction workflows and procurement decisions

The landscape for nucleic acid extraction is undergoing transformative shifts driven by technological convergence, evolving diagnostic demands, and changing laboratory models. First, advances in magnetic bead chemistries, microfluidics, and disposable consumable design have improved extraction robustness, enabling platforms to handle diverse sample types with higher purity and yield consistency. In parallel, the proliferation of modular software ecosystems has given rise to more intuitive touch screen interfaces that reduce operator variability and shorten onboarding times.

Second, the clinical and research communities are pushing for faster diagnostics and decentralized testing pathways, which is encouraging manufacturers to design compact, fully and semi-automated instruments that fit near-patient or satellite lab footprints. This movement toward distributed testing intersects with requirements for connectivity and remote monitoring, prompting integration of digital telemetry, cloud-based protocol updates, and secure data logging.

Third, strategic collaborations between instrument makers and reagent suppliers are accelerating end-to-end workflow validation. Such partnerships enhance the user experience by guaranteeing reagent-instrument compatibility, documented performance, and simplified regulatory submissions. Consequently, combination offerings-instrument plus consumable kits with validated workflows-are increasingly important for procurement committees that value turnkey solutions.

Finally, competitive pressures and customer expectations are reshaping business models. Companies invest in lifecycle support, software updates, and consumable ecosystems to create recurring revenue streams and to lock in interoperability. As a result, purchasers now evaluate not only instrument performance but also long-term service, supply continuity, and digital capabilities when selecting touch screen extraction platforms.

Assessing how tariff-driven supply chain realignments through 2025 have reshaped sourcing, manufacturing footprints, and procurement priorities for laboratory instrumentation

United States tariff actions through 2025 have influenced global supply chains for laboratory instrumentation and consumables by altering the economics of cross-border manufacturing, sourcing, and final assembly. Tariff measures have led manufacturers to reassess component provenance, encouraging relocation or diversification of critical subassembly production to mitigate duty exposure and maintain price competitiveness in end markets. Consequently, procurement teams are increasingly attentive to the geographic origin of instruments and reagents, seeking clarity on tariff risk embedded in supplier quotations.

In addition to manufacturing realignment, tariffs have driven demand for suppliers that can demonstrate resilient logistics and established alternative sourcing channels. This has elevated the importance of supplier transparency regarding their tier-1 and tier-2 vendors, as well as their contingency plans for input materials. For buyers, it has become prudent to prioritize vendors with multi-region supply footprints or local assembly capabilities that can limit tariff-driven cost volatility and minimize lead-time disruption.

Moreover, tariffs have accelerated the trend toward vertical integration in some segments, where companies internalize production of high-value components to reduce exposure to external duties. While vertical integration can improve margin resilience for suppliers, it also reshapes competitive dynamics and may limit the pool of independent technology partners available to end users. Therefore, organizations must weigh trade-offs between securing stable supply and preserving access to innovative third-party technologies.

Finally, regulatory and procurement stakeholders are more likely to require clear documentation of country-of-origin and cost components. As a result, suppliers that offer transparent, audit-ready supply chain information gain a competitive advantage among institutional purchasers focused on fiscal predictability and operational continuity.

Detailed segmentation-driven insights that align application priorities, end-user operational models, extraction technologies, automation choices, and throughput requirements

Insightful segmentation analysis reveals differentiated demand drivers and product requirements across use cases, end users, technology modalities, automation levels, and throughput needs. Based on application, end users prioritize instruments differently: infectious disease testing-split into bacterial and viral workflows-commands high expectations for rapid turnaround, contamination control, and validated kits for clinical diagnostics, while oncology and genetic testing emphasize nucleic acid integrity and compatibility with downstream sequencing and amplification. Agricultural and food testing, and environmental testing, require adaptability to complex matrices and robustness against inhibitors.

Based on end user, academic and research institutes often value flexibility for method development and open-protocol access, clinical diagnostic labs require validated, regulatory-compliant workflows with tight traceability features, and contract research organizations expect throughput scalability and batch tracking. Food testing labs and pharmaceutical and biotech companies focus on repeatability, chain-of-custody controls, and integration with laboratory information management systems to support quality and compliance.

Based on technology, magnetic bead methods offer broad sample-type compatibility and are frequently paired with closed systems for contamination control, anion exchange can excel for specific nucleic acid classes and high purity demands, and silica membrane approaches remain attractive for low-complexity workflows requiring minimal instrumentation. These technology choices interact with automation level expectations: fully automated systems cater to high-reliability, low-touch operations and are favored in clinical diagnostics and large CROs, whereas semi-automated platforms appeal to research and small lab settings that need control over specific steps.

Based on throughput, high-throughput instruments are engineered for continuous operation and plate-based processing, medium-throughput platforms balance flexibility with reasonable batch sizes, and low-throughput devices optimize for decentralized or near-patient settings. Collectively, these segmentation insights show that purchasing decisions are nuanced and need to align application-specific performance criteria with end-user operational models, preferred extraction chemistry, desired automation level, and required throughput.

Regional dynamics shaping procurement and deployment strategies with unique regulatory, manufacturing, and service expectations across the Americas, EMEA, and Asia-Pacific

Regional dynamics exhibit distinct drivers that influence adoption patterns and vendor strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, investment in clinical diagnostics and centralized laboratory infrastructures has supported adoption of fully automated, high-throughput platforms for infectious disease surveillance and genomic applications. Procurement processes in the region emphasize regulatory compliance, quality management systems, and total cost of ownership when evaluating instrument ecosystems.

Moving to Europe, Middle East & Africa, diverse regulatory environments and varying laboratory maturity levels create a heterogeneous demand landscape. Western Europe tends to favor validated turnkey solutions and strong after-sales support, while parts of the Middle East & Africa present opportunities for portable, semi-automated systems that address constrained laboratory capacity and regional infectious disease burdens. Intermediary markets often seek vendors capable of providing training, service networks, and flexible financing arrangements.

In the Asia-Pacific region, rapid expansion of molecular diagnostics capacity, strong investments in life sciences research, and a growing base of local manufacturing have created a competitive environment for both international and indigenous suppliers. Buyers in the region increasingly value localized support, shorter lead times, and reagent compatibility with prevalent sample types. Moreover, government-driven testing initiatives and public-private partnerships have stimulated demand for scalable solutions that can be deployed across urban and decentralized testing sites.

Across all regions, connectivity, data integrity, and service readiness remain core considerations. Vendors that can align product design with regional regulatory regimes, offer resilient supply chains, and provide scalable service models will be best positioned to meet heterogeneous global demand patterns.

How integrated product portfolios, consumable ecosystems, and aftermarket services define vendor competitiveness and influence procurement frameworks for laboratory instruments

Competitive landscapes for touch screen nucleic acid extraction platforms are influenced by portfolios that combine hardware engineering, proprietary consumables, software ecosystems, and service capabilities. Leading vendors increasingly compete on the basis of integrated workflows that deliver validated instrument-reagent pairings, comprehensive documentation for compliance, and modular upgrade paths that extend platform longevity. This has raised the bar for new entrants, who must demonstrate not only technical differentiation but also the ability to support long-term service and supply requirements.

Strategic partnerships are common as firms seek to accelerate time to market and broaden application coverage. Collaborations between instrument manufacturers and reagent developers create bundled solutions that simplify validation for clinical and regulated environments. Additionally, aftermarket services-such as remote diagnostics, predictive maintenance, and software-as-a-service offerings-are shaping purchasing decisions by reducing downtime and improving lifecycle economics.

Intellectual property and proprietary consumable lock-ins also influence competitive positioning. Suppliers with differentiated protocols and consumable ecosystems may secure recurring revenue streams, while those that adopt more open architectures can attract research-focused customers seeking customization. Therefore, end users must evaluate trade-offs between closed, optimized systems and open, flexible platforms based on their operational priorities.

Finally, agility in regulatory support and the capacity to provide localized training and technical service remain key differentiators. Organizations that can deliver rapid technical onboarding and demonstrate clear pathways for regulatory compliance will maintain an advantage in both clinical and research markets.

Actionable initiatives for manufacturers and service providers to enhance interoperability, supply-chain resilience, and customer adoption of touchscreen extraction platforms

Industry leaders can translate market momentum into sustainable advantage by pursuing a set of actionable, operationally focused initiatives. First, invest in interoperable, user-centric software design that links touch screen controls with cloud-enabled protocol management, audit trails, and remote support functions. Doing so reduces onboarding friction and increases instrument uptime across distributed laboratory networks. Second, prioritize validated instrument-reagent pairings and publish robust application notes to shorten customer validation time and to lower barriers to clinical adoption.

Third, strengthen supply-chain transparency by mapping critical components, identifying alternate suppliers, and communicating country-of-origin details to customers. This reduces procurement uncertainty and mitigates tariff exposure. Fourth, expand service footprints and training capabilities to support regional customers, especially in markets with nascent molecular infrastructure. Onsite training, virtual classrooms, and certified service partners can significantly improve customer retention and accelerate deployment.

Fifth, evaluate pricing models that align capital and consumable revenue streams with diverse customer budgets. Flexible financing, reagent subscription plans, and performance-based service agreements can expand addressable markets while smoothing revenue variability. Sixth, cultivate strategic collaborations with clinical laboratories, research consortia, and reagent developers to co-develop validated workflows tailored to priority applications such as infectious disease, oncology, and genetic testing.

By executing these measures, industry leaders will be better positioned to meet operational expectations, reduce adoption friction, and build defensible commercial models that tie instrument performance to long-term customer success.

A mixed-methods research approach combining primary stakeholder interviews, secondary technical validation, and scenario analysis to ensure actionable and defensible insights

This study employed a mixed-methods research methodology that balances primary stakeholder engagement with systematic secondary synthesis to deliver robust, actionable insights. Primary inputs included structured interviews and qualitative discussions with laboratory managers, procurement officers, clinical directors, and technical leads across academic, clinical, contract research, food testing, and industrial laboratories. These conversations explored real-world workflow constraints, procurement criteria, and user expectations for touch screen interfaces and extraction chemistries.

Secondary research complemented primary findings by reviewing technical literature, regulatory guidance documents, and product specifications to validate claimed performance attributes and to assess technological maturity across magnetic bead, silica membrane, and anion exchange modalities. The methodology placed particular emphasis on triangulating vendor documentation with independent performance validations and published assay workflows to ensure reliability of technical claims.

Analytical frameworks were applied to segment demand by application, end user, technology, automation level, and throughput. For regional analysis, supply-chain mapping and policy reviews were used to assess sourcing risks and service delivery constraints. The approach also included scenario-based sensitivity checks to understand how tariff shifts, supply disruptions, or regulatory changes could influence procurement priorities.

Throughout the research lifecycle, data quality controls were enforced via source traceability, interview protocol standardization, and peer review of analytical interpretations. The result is a synthesis that aligns qualitative evidence with document-based verification to support confident decision-making by commercial, clinical, and procurement stakeholders.

Concluding perspectives on how touchscreen extraction platforms unify human-centered design, molecular performance, and supply-chain resilience to support evolving laboratory needs

Touch screen nucleic acid extraction instruments occupy a pivotal role at the intersection of human factors, molecular performance, and operational resilience. Across applications-from infectious disease diagnostics to oncology profiling-these platforms offer a pragmatic path to standardize workflows, improve reproducibility, and support compliance through integrated digital controls. As laboratories evolve toward decentralized testing and higher automation, touch-enabled interfaces will continue to reduce training burdens and facilitate rapid scale-up of molecular capabilities.

Supply-chain dynamics and tariff considerations have underscored the need for transparency and regional agility, making manufacturing footprint strategies and supplier diversification critical for sustained delivery. Vendors that combine validated instrument-reagent pairings with robust service networks and clear supply-chain documentation will be best positioned to capture demand across heterogeneous regional markets.

Finally, buyers should evaluate platforms holistically, considering not only extraction performance but also software interoperability, consumable economics, and long-term service commitments. By aligning procurement decisions with operational models and strategic priorities, organizations can adopt extraction solutions that deliver immediate procedural benefits while supporting future growth and regulatory expectations.

In sum, the trajectory for touch screen nucleic acid extraction technologies points toward greater integration, user-centricity, and supply-chain sophistication, offering a compelling value proposition for laboratories that must reconcile high-quality molecular outputs with scalable operational workflows.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Touch Screen Nucleic Acid Extraction Instrument Market, by Technology

  • 8.1. Anion Exchange
  • 8.2. Magnetic Bead
  • 8.3. Silica Membrane

9. Touch Screen Nucleic Acid Extraction Instrument Market, by Automation Level

  • 9.1. Fully Automated
  • 9.2. Semi-Automated

10. Touch Screen Nucleic Acid Extraction Instrument Market, by Throughput

  • 10.1. High Throughput
  • 10.2. Low Throughput
  • 10.3. Medium Throughput

11. Touch Screen Nucleic Acid Extraction Instrument Market, by Application

  • 11.1. Agricultural And Food Testing
  • 11.2. Environmental Testing
  • 11.3. Genetic Testing
  • 11.4. Infectious Disease
    • 11.4.1. Bacterial
    • 11.4.2. Viral
  • 11.5. Oncology

12. Touch Screen Nucleic Acid Extraction Instrument Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Clinical Diagnostic Labs
  • 12.3. CROs
  • 12.4. Food Testing Labs
  • 12.5. Pharma And Biotech Companies

13. Touch Screen Nucleic Acid Extraction Instrument Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Touch Screen Nucleic Acid Extraction Instrument Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Touch Screen Nucleic Acid Extraction Instrument Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Touch Screen Nucleic Acid Extraction Instrument Market

17. China Touch Screen Nucleic Acid Extraction Instrument Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. ACON Laboratories, Inc.
  • 18.7. Advanced Biological Laboratories S.A.
  • 18.8. Agilent Technologies, Inc.
  • 18.9. bioMerieux SA
  • 18.10. Bio-Rad Laboratories, Inc.
  • 18.11. Danaher Corporation
  • 18.12. Esco Micro Pte. Ltd.
  • 18.13. F. Hoffmann-La Roche Ltd.
  • 18.14. Geneaid Biotech Ltd.
  • 18.15. NTL Biotech
  • 18.16. PerkinElmer Inc.
  • 18.17. Promega Corporation
  • 18.18. QIAGEN N.V.
  • 18.19. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ANION EXCHANGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ANION EXCHANGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ANION EXCHANGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SILICA MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SILICA MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SILICA MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY HIGH THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY HIGH THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY HIGH THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY LOW THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY LOW THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY LOW THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MEDIUM THROUGHPUT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MEDIUM THROUGHPUT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY MEDIUM THROUGHPUT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AGRICULTURAL AND FOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AGRICULTURAL AND FOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AGRICULTURAL AND FOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CLINICAL DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FOOD TESTING LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FOOD TESTING LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY FOOD TESTING LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 137. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 158. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 165. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY THROUGHPUT, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA TOUCH SCREEN NUCLEIC ACID EXTRACTION INSTRUMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)